Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMiniMed Group, Inc. Common Stock

MiniMed Group, Inc. Common Stock

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
16.71 USD -1.45 ( 7.96%)
Last update at 2026-11-06T21:29:00Z
VOLUME
7292000
Market Cap
6192.51M

Momentum Score

…

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
16.66
Low
18.26
High
52 Week Price Range
10.65
Low
24.43
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
18.16
Dividend Yield
-
Revenue TTM
3222.00M
Revenue Per Share
12.22
Gross Profit TTM
1833.00M
Debt / Equity
0.04
ROE
-8.66%
Net Debt
-153.00M
ROCE
1.25%
Diluted EPS TTM
-1.12

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-04-30 2025-04-30 2024-04-30 2023-04-30
Type yearly yearly yearly yearly
Date 2026-04-30 2025-04-30 2024-04-30 2023-04-30
Income before tax -187.00M -203.00M -70.00M -76.00M
Minority interest -16.00M -15.00M -5.00M -5.00M
Net income -331.00M -250.00M -112.00M -96.00M
Selling general administrative 1183.00M 1131.00M 1057.00M 960.00M
Selling and marketing expenses - 1131.00M 1057.00M 960.00M
Gross profit 1680.00M 1525.00M 1436.00M 1308.00M
Reconciled depreciation 156.00M 143.00M 129.00M 115.00M
Ebit - -36.00M -70.00M -76.00M
Ebitda 49.00M 107.00M 59.00M 39.00M
Depreciation and amortization - 143.00M 129.00M 115.00M
Operating income 49.00M -202.00M -69.00M -69.00M
Other operating expenses 3053.00M 2917.00M 2538.00M 2314.00M
Tax provision 128.00M 48.00M 38.00M 16.00M
Income tax expense 128.00M 48.00M 38.00M 16.00M
Total revenue 3102.00M 2715.00M 2469.00M 2245.00M
Total operating expenses 1631.00M 1727.00M 1506.00M 1377.00M
Cost of revenue 1422.00M 1190.00M 1032.00M 937.00M
Total other income expense net -236.00M -1.00M -1.00M -7.00M
Net income from continuing ops -317.00M -251.00M -108.00M -92.00M
Breakdown 2026-04-30 2025-04-30 2024-04-30 2023-04-30
Type yearly yearly yearly yearly
Date 2026-04-30 2025-04-30 2024-04-30 2023-04-30
Total assets 4630.00M 4201.00M 4094.00M -
Intangible assets 106.00M 131.00M 160.00M -
Other current assets 54.00M 48.00M 42.00M -
Total liab 1019.00M 870.00M 646.00M -
Total stockholder equity 3611.00M 3331.00M 3448.00M -
Other current liab 341.00M 483.00M 309.00M -
Common stock 3.00M - - -
Capital stock 3.00M 0.00M - -
Retained earnings -116.00M 0.00M - -
Good will 2256.00M 2255.00M 2255.00M -
Other assets 1.00M 1.00M 1.00M -
Cash 298.00M 11.00M 54.00M -
Total current liabilities 702.00M 710.00M 518.00M -
Current deferred revenue 15.00M 11.00M 11.00M -
Net debt -153.00M - -46.00M -
Short term debt 145.00M 11.00M 8.00M -
Short long term debt 137.00M - - -
Short long term debt total 145.00M 11.00M 8.00M -
Other stockholder equity 3736.00M 3328.00M 3464.00M -
Total current assets 1348.00M 939.00M 895.00M -
Net receivables 655.00M 570.00M 507.00M -
Inventory 341.00M 310.00M 292.00M -
Accounts payable 163.00M 205.00M 190.00M -
Accumulated other comprehensive income -12.00M 3.00M -16.00M -
Non currrent assets other 208.00M 169.00M 147.00M -
Non current assets total 3281.00M 3261.00M 3198.00M -
Capital lease obligations 8.00M 11.00M 8.00M -
Breakdown 2026-04-30 2025-04-30 2024-04-30 2023-04-30
Type yearly yearly yearly yearly
Date 2026-04-30 2025-04-30 2024-04-30 2023-04-30
Investments 0.00M 0.00M 6.00M -13.00M
Total cashflows from investing activities -233.00M -193.00M -157.00M -180.00M
Total cash from financing activities 716.00M 10.00M 112.00M 185.00M
Net income -317.00M -198.00M -107.00M -92.00M
Change in cash 287.00M -43.00M -4.00M -2.00M
Begin period cash flow 11.00M 54.00M 58.00M 60.00M
End period cash flow 298.00M 11.00M 54.00M 58.00M
Total cash from operating activities -197.00M 140.00M 41.00M -6.00M
Issuance of capital stock 538.00M 0.00M 0.00M -
Depreciation 156.00M 143.00M 129.00M 115.00M
Other cashflows from investing activities -10.00M - -15.00M -
Change to inventory -29.00M -19.00M 5.00M -28.00M
Change to account receivables -538.00M -66.00M -105.00M -70.00M
Other cashflows from financing activities 178.00M 10.00M 112.00M 185.00M
Capital expenditures 223.00M 193.00M 148.00M 167.00M
Change in working capital -166.00M 122.00M -74.00M -90.00M
Stock based compensation 46.00M 41.00M 38.00M 35.00M
Other non cash items 138.00M 34.00M 52.00M 37.00M
Free cash flow -420.00M -53.00M -107.00M -173.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MMED
MiniMed Group, Inc. Common Stock		 -1.45
7.96%		 16.71 - - 1.92 1.71 1.86 92.94
ISRG
Intuitive Surgical Inc		 -15.72
3.36%		 452.80 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 2.75
1.29%		 215.85 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 0.92
0.86%		 107.77 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -1.69
0.79%		 211.86 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

MiniMed Group, Inc. Common Stock

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.

18000 Devonshire Street, Northridge, CA, United States, 91325

763 514 4000

https://www.minimed.com

8000

Name Title Year Born
Ms. Que Thanh Dallara CEO & Director 1974
Mr. Chad J. Spooner Executive VP & CFO 1972
Mr. Ali Dianaty Executive VP and Chief Product & Technology Officer 1975
Ms. Courtney Nelson Wills SVP, General Counsel & Corporate Secretary 1976
Ms. Gillian Chandrasena Senior VP & Chief Human Resources Officer 1974
Mr. Christopher E. Eso President NA
Mr. John Gyurci VP, Chief Accounting Officer & Controller 1971
Mr. Mike Bruggeman SVP & Chief Information Officer NA
Mr. Ryan Weispfenning Head of Investor Relations NA
Ms. Kate Cronin MSN RN SVP & Chief Marketing Officer 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…